甘李药业：股东孙程减持公司股份20000股

Group 1 - Gannee Pharmaceutical announced that Sun Cheng reduced his shareholding by 20,000 shares on August 19, 2025, accounting for 0.0033% of the company's total share capital [2] - The reduction plan has been fully implemented [2] - For the year 2024, Gannee Pharmaceutical's revenue composition is 100% from the pharmaceutical manufacturing industry [2]